Lymphoblasts of the ALL Patient 3 (male, 47 months at first diagnosis) contained TEL (82.5%), AML1 (82.5%), and ABL (70%) gene duplications at the diagnosis. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.